Mukka Proteins Limited has announced the successful completion of its acquisition of Ocean Proteins Private Limited, making the latter a subsidiary effective December 30, 2025. The transaction was completed through the acquisition of equity shares for a total consideration of ₹10.45 crores.

Acquisition Details

The company acquired 1,04,500 equity shares of Ocean Proteins Private Limited at face value of ₹100.00 per share, representing a 51% shareholding in the target entity. The acquisition was completed through cash consideration, with the share transfer finalized on December 30, 2025.

Target Company Profile

Ocean Proteins Private Limited operates as a manufacturer and exporter of frozen fish, shrimp and surimi. The company has established operations with significant financial metrics for FY 2024-25.

Strategic Rationale

The acquisition forms part of Mukka Proteins Limited's strategic investment plans to expand its frozen fish business operations. Ocean Proteins Private Limited was previously a related party of the company under the provisions of the Companies Act, 2013, being an associate company. The investment was executed on an arm's length basis, with promoters having interest in Ocean Proteins Private Limited to the extent of their directorship.

Regulatory Compliance

The acquisition was announced under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The transaction did not require any governmental or regulatory approvals. This development follows previous communications dated May 15, 2025, and August 13, 2025, regarding the company's intention to make further acquisitions of equity shares in Ocean Proteins Private Limited.

Mukka Proteins Limited , a prominent player in the protein industry, has announced a significant delay in its strategic acquisition of a majority stake in its Vietnamese subsidiary. The company has informed stock exchanges about the postponement of its planned acquisition of 70% stake in Mukka Proteins Vietnam Co., Ltd., originally scheduled for completion by December 31, 2025.

Acquisition Overview

The company had initially entered into a Capital Contribution Transfer Agreement to acquire a 70% stake in Mukka Proteins Vietnam Co., Ltd. for an amount not exceeding Rs. 10.00 lakh (equivalent to 165,144,000 Vietnamese Dong). The agreement was signed on August 4, 2025, with the transfer of capital contribution from TRẦN THỊ PHÚC, a shareholder of the Vietnamese entity.

Delay Announcement and Revised Timeline

In its latest communication to the National Stock Exchange of India Limited and BSE Limited, Mukka Proteins Limited has disclosed the delay in execution of the acquisition. The company has provided updated timelines and reasons for the postponement:

Regulatory Challenges

The primary reason cited for the delay is the time-consuming process of obtaining necessary regulatory approvals in Vietnam. The completion of this acquisition remains subject to compliance with the Foreign Exchange Management (Overseas Investment) Regulations, 2022, as well as other regulations that may be notified by the Reserve Bank of India and Vietnamese regulatory authorities.

Transaction Structure

Key aspects of the acquisition remain unchanged:

• The acquisition involves 70% of the issued and paid-up share capital
• Investment amount capped at Rs. 10.00 lakh
• The transaction is not classified as a related party transaction
• No special rights such as director appointment or capital structure restrictions are included
• The parties involved are not related to the promoter or promoter group

Company's Response

Mukka Proteins Limited has assured stakeholders that all necessary steps are being taken to address the delays. The company stated that the acquisition through share transfer will be completed in due course, indicating continued commitment to the Vietnamese expansion despite regulatory hurdles.

Market Implications

While the delay may temporarily impact the company's international expansion timeline, the strategic importance of establishing a foothold in the Southeast Asian market remains intact. The acquisition, once completed, is expected to provide Mukka Proteins Limited with local expertise and operational capabilities in Vietnam, potentially serving as a gateway to the broader regional market.